In ₹ Crore except Per Share 12 Months Ending | Q2 FY24 30/09/2023 | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 98.1 | 96.1 | 98.0 | 100.0 | 108.7 | 125.7 | 137.3 | 145.3 | 153.5 | 155.1 | 166.6 | 155.5 | |
| Other Income | 1.9 | 0.8 | 0.2 | 0.2 | 1.1 | 0.5 | 3.1 | 2.2 | 1.9 | 5.9 | 2.1 | 5.1 | |
| Total Income | 100.1 | 96.9 | 98.2 | 100.2 | 109.8 | 126.1 | 140.4 | 147.5 | 155.4 | 160.9 | 168.7 | 160.6 | |
| Expenses | |||||||||||||
| + Employee Benefit Expense | 18.2 | 20.7 | 21.3 | 21.8 | 23.7 | 24.2 | 25.5 | 28.8 | 29.1 | 29.1 | 29.1 | 31.5 | |
| + Finance Costs | 41.2 | 39.8 | 42.4 | 43.7 | 50.7 | 61.5 | 67.6 | 75.1 | 81.4 | 81.2 | 77.6 | 77.9 | |
| + Depreciation & Amortisation | 0.2 | 0.2 | 0.3 | 0.8 | 0.9 | 1.1 | 1.9 | 1.2 | 1.2 | 1.3 | 3.6 | 1.1 | |
| + Other Expenses | 21.7 | 17.3 | 18.3 | 14.4 | 16.5 | 20.5 | 21.8 | 21.9 | 23.3 | 27.9 | 28.0 | 0.0 | |
| Total Expenses | 83.9 | 83.5 | 83.5 | 85.7 | 88.2 | 108.9 | 133.4 | 153.7 | 151.7 | 150.6 | 159.2 | 149.8 | |
| EBITDA | 55.5 | 52.6 | 57.2 | 58.9 | 72.1 | 79.4 | 73.5 | 67.9 | 84.4 | 86.9 | 88.5 | 84.7 | |
| EBIT | 55.4 | 52.4 | 56.9 | 58.0 | 71.2 | 78.3 | 71.5 | 66.7 | 83.2 | 85.6 | 84.9 | 83.6 | |
| Profit | |||||||||||||
| PBT before Exceptional Items | 16.1 | 13.4 | 14.7 | 14.5 | 21.6 | 17.3 | 7.0 | -6.2 | 3.7 | 10.3 | 9.4 | 10.9 | |
| + Exceptional Items | 95.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.7 | 0.0 | |
| Pretax Income | 112.0 | 13.4 | 14.7 | 14.5 | 21.6 | 17.3 | 7.0 | -6.2 | 3.7 | 10.3 | 7.8 | 10.9 | |
| + Current Tax | -25.3 | 2.6 | 23.7 | 3.1 | -13.0 | -1.1 | 11.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Deferred Tax | 54.1 | 0.8 | -20.7 | 0.6 | 18.7 | 5.9 | -10.5 | -1.5 | 0.9 | 2.7 | 2.4 | 2.7 | |
| Tax Expense | 28.8 | 3.4 | 3.0 | 3.7 | 5.6 | 4.7 | 0.6 | -1.5 | 0.9 | 2.7 | 2.4 | 2.7 | |
| Net Income | 83.2 | 10.0 | 11.7 | 10.8 | 16.0 | 12.6 | 6.4 | -4.7 | 2.8 | 7.7 | 5.4 | 8.1 | |
| + Net Income — Continuing Ops | 83.2 | 10.0 | 11.7 | 10.8 | 16.0 | 12.6 | 6.4 | -4.7 | 2.8 | 7.7 | 5.4 | 8.1 | |
| + Other Comprehensive Income | -0.1 | 0.2 | -0.6 | 0.6 | 0.3 | 0.1 | -0.5 | 0.3 | 0.5 | 0.8 | -0.3 | -0.2 | |
| Total Comprehensive Income | 83.1 | 10.3 | 11.1 | 11.4 | 16.3 | 12.7 | 5.9 | -4.4 | 3.3 | 8.4 | 5.0 | 7.9 | |
| Per Share | |||||||||||||
| Basic EPS | 50.60 | 6.09 | 7.10 | 6.57 | 9.71 | 7.63 | 3.90 | -2.84 | 1.72 | 4.65 | 3.26 | 4.94 | |
| Diluted EPS | 50.60 | 6.09 | 7.10 | 6.57 | 16.28 | 7.63 | 3.90 | -2.84 | 1.72 | 4.65 | 3.26 | 4.94 | |
| Revenue Detail — as filed | |||||||||||||
| + Rental Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 7.0 | |
| + Dividend Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Fees & Commission Income | 6.9 | 6.3 | 7.3 | 5.5 | 6.1 | 5.7 | 6.9 | 6.4 | 6.5 | 6.7 | 8.0 | 0.0 | |
| + Net Gain on Fair Value Changes | 0.4 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Net Loss on Fair Value Changes | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Net Gain on Derecognition — Amortised Cost | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 11.4 | 0.0 | |
| Expense Detail — as filed | |||||||||||||
| + Fees & Commission Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 31.4 | |
| + Impairment on Financial Instruments | 2.7 | 5.5 | 1.1 | 4.9 | -3.6 | 1.6 | 16.6 | 26.7 | 16.7 | 11.2 | 21.0 | 8.0 | |
| Other Comprehensive Income — detail | |||||||||||||
| + Other Comprehensive Income | -0.1 | 0.2 | -0.6 | 0.6 | 0.3 | 0.1 | -0.5 | 0.3 | 0.5 | 0.8 | -0.3 | -0.2 | |
| + Items NOT to be Reclassified to P&L | -0.1 | 0.3 | -0.8 | 0.5 | 0.3 | 0.2 | -0.5 | 0.3 | 0.6 | 1.0 | -0.5 | -0.2 | |
| + Tax on Items NOT to be Reclassified | — | — | — | — | — | — | 0.0 | 0.1 | 0.2 | 0.3 | -0.1 | -0.1 | |
| + Tax on Items NOT to be Reclassified — alt tag | -0.0 | 0.1 | -0.2 | -0.1 | 0.0 | 0.0 | — | — | — | — | — | — | |
| Per Share — as-filed variants | |||||||||||||
| Basic EPS — Continuing Operations | 50.60 | 6.09 | 7.10 | 6.57 | 9.71 | 7.63 | 3.90 | -2.84 | 1.72 | 4.65 | 3.26 | 4.94 | |
| Diluted EPS — Continuing Operations | 50.60 | 6.09 | 7.10 | 6.57 | 16.28 | 7.63 | 3.90 | -2.84 | 1.72 | 4.65 | 3.26 | 4.94 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||||||||
| Related-party Transactions — During the Period | — | — | — | — | — | — | 22.9 | — | 19.6 | — | 29.1 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||||||||||
| Gross Profit | 98.1 | 96.1 | 98.0 | 100.0 | 108.7 | 125.7 | 137.3 | 145.3 | 153.5 | 155.1 | 166.6 | 155.5 | |
| Gross Margin % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Adjusted (ex-Exceptional Items) — derived | |||||||||||||
| Pretax Income (Adjusted, as filed) | 16.1 | 13.4 | 14.7 | 14.5 | 21.6 | 17.3 | 7.0 | -6.2 | 3.7 | 10.3 | 9.4 | 10.9 | |
| − Exceptional Items (reconciliation) | 95.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.7 | 0.0 | |
| Net Income Adj (tax-effected) | 12.0 | 10.0 | 11.7 | 10.8 | 16.0 | 12.6 | 6.4 | -4.7 | 2.8 | 7.7 | 6.5 | 8.1 | |
| EPS Adj | 7.29 | 6.09 | 7.10 | 6.57 | 9.71 | 7.63 | 3.90 | -2.84 | 1.72 | 4.65 | 3.97 | 4.94 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Filed Debt Equity | — | — | — | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
| Interest Earned | 90.3 | 89.3 | 90.5 | 94.3 | 102.3 | 119.8 | 130.2 | 138.8 | 146.9 | 148.3 | 146.9 | 148.5 | |
| Paid Up Equity Capital | 16.4 | 16.4 | 16.4 | 16.4 | 16.4 | 16.4 | 16.4 | 16.4 | 16.4 | 16.4 | 16.4 | 16.4 | |